Kinnate Biopharma
KNTE
$2.65
Share price
0.00%
Change (1 day)
-22.06%
Change (1 year)
Categories
Earnings for Kinnate Biopharma (KNTE)
Earnings in 2023 (TTM): -$0.12 B
According to Kinnate Biopharma's latest financial reports the company's current earnings (TTM) are -$0.12 B. In 2022 the company made an earning of -$0.12 B a decrease over its 2021 earnings that were of -$90.12 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Kinnate Biopharma from 2020 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.12 B | 0.41% |
| 2022 | -$0.12 B | 31.53% |
| 2021 | -$90.12 M | 150.3% |
| 2020 | -$36.01 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | -4.13% | 🇺🇸 USA |